Annual General Meeting Approves Dividend Proposal

28 May 2020 - The Annual General Meeting approved the actions of the Executive Board and the Supervisory Board of Merck KGaA, Darmstadt, Germany for fiscal 2019 by a large majority and approved all of the resolutions on the agenda, including the proposed dividend of € 1.30 per share, an increase of € 0.05 over the previous year.

Related News

View All News
  1. Press Releases

    Annual General Meeting Approves Dividend Proposal

    Merck KGaA, Darmstadt, Germany held its 25th Annual General Meeting today. The company made use of the possibilities afforded by the German legislator in view of the coronavirus pandemic and conducted ...

    2020/05/28

  • Presence & voting results

    Here you will find the presence and voting results.
    Read more
  • Speech by the CEO

    Speech by Stefan Oschmann, Chairman of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany (Pre-released May 25, 2020. Check against delivery.)
    Read the speech

Documents for the annual general meeting of Merck KGaA, Darmstadt, Germany on 28 May 2020

     
  Invitation for the Annual General Meeting of Merck KGaA, Darmstadt, Germany on 28 May 2020 PDF (English)
PDF (German)
  Annual report of Merck KGaA, Darmstadt, Germany for the fiscal year 2019
including the consolidated financial statements, combined Management report and Supervisory Board report (Version as of May 12, 2020)
PDF
  Single entity financial statements of Merck KGaA, Darmstadt, Germany for the fiscal year 2019 
including the combined Management report and Supervisory Board report (Last update May 12th 2020)

PDF

 

Information relating to agenda item 7

 

 

Control and profit and loss transfer agreement between Merck KGaA, Darmstadt, Germany and BSSN UG (haftungsbeschränkt)

PDF 
(German only)

 

Joint Report of the Executive Board of Merck KGaA, Darmstadt, Germany, and the Management Board of BSSN UG (haftungsbeschränkt)

PDF
 

Single entity financial statements of Merck KGaA, Darmstadt, Germany for the fiscal year 2018

2018 (PDF)
 

Single entity financial statements of Merck KGaA, Darmstadt, Germany for the fiscal year 2017

2017 (PDF)
 

Single entity financial statements of Merck KGaA, Darmstadt, Germany for the fiscal year 2016

2016 (PDF)
 

Single entity financial statements of BSSN UG (prior Burkard Schäfer Verwaltungsgesellschaft UG) for the fiscal year 2018

PDF 
(German only)
 

Single entity financial statements of BSSN UG (prior Burkard Schäfer Verwaltungsgesellschaft UG) for the fiscal year 2017

PDF 
(German only)
 

Single entity financial statements of BSSN UG (prior Burkard Schäfer Verwaltungsgesellschaft UG) for the fiscal year 2016

PDF 
(German only)

Additional Information

     
 

Explanation of shareholder rights

PDF (English)
PDF (German)
 

Information on participation – exercise of proxy voting

PDF (English)
PDF (German)
 

Information on data privacy for shareholders

PDF (English)
PDF (German)
 

Articles of association of Merck KGaA, Darmstadt, Germany

PDF
 

Sample of the agenda voting card

PDF (German only)
 

Competence-matrix for Supervisory Board candidates

PDF
 

Overview of auditor rotation

PDF
 

Speech by Stefan Oschmann, Chairman of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany.
(Pre-released May 25, 2020. Check against delivery.)

PDF
 

Presence and voting results

PDF

Previous Annual General Meetings

Annual General Meeting Archive

Archived documents for the past annual general meetings

Read More

Related News

View All News
  1. Press Releases

    Annual General Meeting Approves Dividend Proposal

    Merck KGaA, Darmstadt, Germany held its 25th Annual General Meeting today. The company made use of the possibilities afforded by the German legislator in view of the coronavirus pandemic and conducted ...

    2020/05/28